(2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate

Product Name (2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate
Alias Fmoc-Pro
Mininmum Order 1g
Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
Price Inquiry sales9@bouling-chem.com
Manufacturer Bouling Chemical Co., Limited
CONTACT NOW

In terms of specification, (2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate is supplied with ≥99% HPLC purity and ≥99% enantiomeric excess, making it suitable for Fmoc-based solid-phase peptide synthesis.

Specifications

HS Code	214643
Chemical Name	(2S)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylate
Molecular Formula	C20H19NO4
Molecular Weight	337.37
Appearance	Typically a solid (color may vary depending on purity)
Solubility	Soluble in some organic solvents like dichloromethane, less soluble in water
Chirality	Has (2S) configuration, is chiral
Functionality	Contains a pyrrolidine ring and a fluorenylmethoxycarbonyl (Fmoc) protecting group
Melting Point	Approximately 120 - 130 °C (varies with purity)
Stability	Stable under normal conditions, but sensitive to strong acids, bases and high temperatures

As an accredited (2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

Packing & Storage

Packing	5 g of (2S)-1-[(9H - Fluoren-9 - ylmethoxy)carbonyl]pyrrolidine - 2 - carboxylate in sealed vial.
Shipping	The chemical (2S)-1-[(9H - Fluoren-9 - ylmethoxy)carbonyl]pyrrolidine - 2 - carboxylate is shipped in well - sealed, corrosion - resistant containers. Special care is taken to prevent exposure to moisture and ensure compliance with chemical transportation regulations.
Storage	(2S)-1-[(9H - Fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylate should be stored in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it separately from incompatible substances to avoid chemical reactions.

Application of (2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate

In automated microwave-assisted solid-phase peptide synthesis (MW-SPPS), the incorporation of (2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylate (Fmoc-Pro-OH) regularly demands deviation from standard coupling protocols. The pyrrolidine ring houses a secondary amino group with steric hindrance that lowers acylation kinetics by approximately 30–50% compared to primary-amine Fmoc-amino acids, measured on a low-loading Rink amide resin 0.18–0.25 mmol/g. Few automated synthesizers apply generic 4-equivalents-plus-HBTU conditions and generate a des-Pro deletion peptide exceeding 3.5 area% by UPLC at residue position 2 or 3. The production-scale correction involves raising the stoichiometric ratio to 5.0–6.0 equivalents of Fmoc-Pro-OH, activating with HATU (4.8–5.8 eq.) and 10–12 eq. of DIPEA in DMF, and executing a double-coupling cycle at 50 °C for 8–10 min per contact time under microwave irradiation at 20 W. The activated ester consumption must be confirmed by post-coupling FDNB-test negativity before proceeding to the next Fmoc-deprotection step. Failure to extend the coupling leads to truncation sequences that co-elute with the target peptide during preparative RP-HPLC on a 10 μm C18, 250 × 50 mm column, increasing the pooling window and reducing yield below 42% of theoretical. The specification for usable resin-bound Fmoc-Pro after a single coupling is set at a Kaiser test ΔA₅₇₀ ≤ 0.03 absorbance units; otherwise, a third coupling at 60 °C for 5 min is triggered automatically. Compliance with this process parameter rests on USP <1043> auxiliary control for ancillary reagents and on documented resin batch records that track swelling volume in DMF within 4.2–5.8 mL/g. The end products are proline-bearing oligopeptides for metabolic disease targets—e.g., GLP-1 receptor agonist fragments—where the integrity of the Pro⁷ or Pro³⁶ position is critical for receptor activation and enzymatic stability in plasma.The downstream risk intensifies when Pro appears at the C-terminal dipeptide ester bond on a 2-chlorotrityl chloride resin. Here, the nucleophilic pyrrolidine nitrogen of the terminal Fmoc-Pro-dipeptidyl ester can attack the ester carbonyl in a base-catalyzed intramolecular cyclization, releasing a diketopiperazine (DKP) that detaches the peptide from the solid support. The DKP side reaction manifests as a 15–28% loss of anchoring sites within 4 h in 20% piperidine/DMF deprotection medium at 25 °C, as quantified by Fmoc-release spectrometry at 301 nm. To suppress the ring closure, the dipeptidyl-resin is subjected to a shortened deprotection exposure of 2 × 5 min with 0.1 M HOBt added to the piperidine solution as a mild acid buffering agent, or alternatively using 2% DBU + 2% piperidine in DMF for 3 min. Process validation data from a 50 mmol scale peptide synthesis campaign documented that residual linked peptide after 10 coupling cycles remained above 0.18 mmol/g when the triethylamine-wash step was eliminated and replaced with a 0.4% trifluoroacetic acid in DCM neutralizing rinse immediately after Fmoc removal. The compliance boundary is set by GMP intermediate holding time studies: the piperidine-washed resin must be washed to a conductivity of less than 3 μS/cm in the DMF filtrate, as checked by an in-line conductivity probe, to prevent carryover alkalinization during the next acylation. Every batch of Fmoc-Pro-OH is prescribed against Ph. Eur. 10.0 monograph for specific rotation (−32.0° to −36.0°, c=1 in DMF) to confirm enantiomeric identity, and residual acetone and ethyl acetate must be below 50 ppm and 100 ppm respectively per ICH Q3C Option 1. The terminal product is a full-length peptide where the Pro residue remains intact, avoiding the −18 Da mass deficit that triggers a customer quality rejection.

Will Diketopiperazine Formation Compromise Resin-Loaded Proline-Terminal Peptide Chains?

When the synthetic strategy requires anchoring the C-terminal Pro onto a Wang or 2-chlorotrityl resin via an ester linkage, the susceptibility to base-promoted DKP release becomes the dominant control point for overall crude purity. The DKP derived from Pro-X sequences (where X is any L-amino acid) forms via a six-membered transition state that is kinetically favored when the penultimate Pro s-cis amide conformation aligns the nucleophilic nitrogen with the ester carbonyl at a distance shorter than 3.2 Å. A 0.1 mmol scale trial on H-Pro-2-chlorotrityl resin loaded at 0.62 mmol/g showed that after incorporation of the second Fmoc-amino acid and a standard 20% piperidine deprotection of 20 min, the free amine dipeptidyl ester cyclized with a half-life of only 47 min at 22 °C in DMF, leading to an area-% of des-dipeptide product exceeding 41% after 2 h. Manufacturing protocols therefore mandate a switch to the less labile trityl-type super acid-sensitive resin, where the amino acid ester is formed via the 2-ClTrt linker, known to sterically shield the ester carbonyl. The Fmoc-Pro-OH coupling onto this resin is conducted with 1.2 eq. Fmoc-Pro-OH and 2.4 eq. DIPEA in DCM for 60 min, followed by end-capping with methanol/DIEA (9:1 v/v). The resultant substitution level is monitored by Fmoc-release spectrophotometry, targeting 0.35–0.50 mmol/g. Residual piperidine in the resin after Fmoc removal is stripped by three sequential washes with DMF-modified with 0.5% formic acid, lowering the pH of the resin microenvironment to below 7.8, as measured by a slurry pH probe. Subsequent coupling cycles with the elongated chain are performed at 0.2 M concentration within 30 min of neutralization to limit the time window for DKP generation. The final peptide, cleaved with 95% TFA, 2.5% TIS, 2.5% water for 2 h, typically retains less than 0.8% of the DKP-spliced fragment as determined by LC-MS extracted ion chromatogram at +2 Da adduct masses. This impurity profile complies with ICH Q3A reporting threshold for new peptide drug substances.

Liquid-Phase Fragment Condensation of Fmoc-Proline and its Role in Prolyl-Prolyl Sequences

When convergent synthesis of long proline-rich peptides is executed in solution rather than on a solid support, Fmoc-Pro-OH serves as a protected building block for C-terminal fragments that are later condensed without epimerization. A typical fragment assembly couples Fmoc-Pro-OH with H-Pro-OMe·HCl using EDC·HCl (1.05 eq.) and HOBt hydrate (1.05 eq.) in dichloromethane, with N-methylmorpholine (2.3 eq.) at −15 °C to 0 °C to maintain optical rotation above −31.5°. The reaction is monitored by TLC (chloroform/methanol/acetic acid 85:10:5), and upon complete consumption of the amine component, the mixture is quenched with 5% citric acid to remove excess coupling agent, followed by brine washing to recover the Fmoc-Pro-Pro-OMe in the organic phase. The methyl ester is subsequently saponified with 1.1 eq. of LiOH in THF/water (3:1) at 0 °C for 45–60 min, yielding Fmoc-Pro-Pro-OH, which precipitates upon neutralization at pH 4.5 and is recrystallized from ethyl acetate/hexane. This protected dipeptide acid is activated with HBTU/DIPEA and coupled to the N-terminus of a resin-bound or solution-phase peptide segment under standard conditions. The critical quality attributes at the dipeptide intermediate stage are residual EDC·HCl-related byproducts (measured as isourea content by ¹H-NMR, singlet at 3.02 ppm less than 0.05 mole%) and chiral purity: the D-Pro-D-Pro diastereomer must not exceed 0.15 area% on a Chiralpak® IA column with hexane/ethanol/TFA 80:20:0.1 mobile phase. All residual solvents—DCM, THF, ethyl acetate—must conform to Ph. Eur. 5.4 class 2 limits, with THF below 720 ppm. The terminal use is in large-scale manufacture of vasopressin and oxytocin analogues, where the Pro-Pro sequence provides a β-turn scaffold that improves metabolic resistance to aminopeptidase, and the batch documentation must contain a statement of compliance with EMA/CHMP/CVMP/QWP/437/2010 for active substance starting materials.When the secondary amine of Fmoc-Pro-OH is acylated onto a sterically demanding N-methyl amino acid or onto an N-alkyl resin linker, the coupling efficiency drops below the threshold detectable by ninhydrin, and alternative process analytical technology becomes indispensable. A mid-scale campaign producing 500-g batches of a cyclopeptide precursor placed an in-line UV flow cell after the recirculation pump of a 50 L glass-lined reactor operating under nitrogen blanket. The derivatization method used activated Fmoc-Pro-Cl prepared in situ from Fmoc-Pro-OH and 1.05 eq. of thionyl chloride in dichloromethane at 30 °C for 2 h, then evaporated to dryness, redissolved in DMF, and delivered to the N-methylamine resin at 2.8 equivalents. The progress of amide bond formation was followed by the decrease in chloride-ion conductivity in the DMF stream and by the disappearance of the Fmoc-Pro-Cl carbonyl absorbance at 1795 cm⁻¹ in FTIR-ATR. When the absorption band flattened after 75 min at 45 °C, a sample of the resin was taken, washed, and subjected to microcleavage with 1% TFA in DCM, and the released Fmoc-Pro-N-methyl residue was quantified by RP-HPLC against a calibration curve of Fmoc-Pro-OH (linearity r² > 0.999 from 0.01–2.0 mg/mL). This off-line check confirmed a loading of 0.32 mmol/g against a theoretical 0.35 mmol/g, meeting the acceptance criterion of ≥ 90% theoretical. The residual Fmoc-Pro-OH that could hydrolyze during the aqueous workup was removed by a 5% sodium carbonate wash, monitored such that Fmoc chromophore in the aqueous phase did not exceed 0.02 AU at 301 nm. The analytical instrumentation was qualified per USP <1058>, with wavelength accuracy verified by holmium oxide filter and a blank subtraction protocol to correct for baseline drift caused by DMF vapor. The final purified cyclopeptide, containing a central N-methyl-proline residue, was obtained with 99.4% purity and an epimerized D-Pro intermediate below 0.08%, satisfying the ICMRA nitrosamine-free declaration and the ICH M7 limit for mutagenic byproducts from the coupling activator.

Regulatory Starting Material Specifications for Fmoc-Proline in Multi-Kilogram Peptide API Manufacturing

In a commercial peptide active pharmaceutical ingredient (API) supply chain, Fmoc-Pro-OH is classified as a regulatory starting material under ICH Q11, subject to a defined impurity profile held in a Type II drug master file. The acceptance specification requires assay (anhydrous, solvent-free basis) by perchloric acid titration in non-aqueous medium between 98.0% and 102.0%, with individual impurities at 0.10% maximum and total impurities below 1.0% determined by HPLC with UV detection at 265 nm—the wavelength where the fluorenyl ring absorbs but most non-fluorenyl adducts remain transparent. The free L-proline content, originating from incomplete Fmoc protection or storage hydrolysis, is limited to < 0.5% because free amino acid can terminate chain elongation and create a truncated peptide that co-purifies with the target on ion-exchange chromatography. The D-Pro enantiomer is capped at 0.3% via chiral HPLC using a Chiralpak® ZWIX(+) column under ammonium formate buffer/acetonitrile 45:55; the presence of D-Pro leads to diastereoisomeric peptide variants that reduce potency and must be controlled per FDA 21 CFR 211.160(b) in-process testing. For an industrialized multi-kilogram synthesis of a 34-mer peptide amide, the consumption ratio of Fmoc-Pro-OH is approximately 2.8–3.5 kg per 1 kg of purified API, with the majority entering the waste stream during excess reagent washes. The peptide manufacturer performs an incoming identity test via IR spectrum matching against a NIST-traceable reference and specific rotation measurement, followed by a full release that replicates the CoA methods under cGMP 21 CFR 211.84. Any batch exhibiting Fmoc-β-Ala-OH cross-contamination above 0.05% is rejected, as the β-amino acid is a common process-related substance from Fmoc-OSu manufacturing that inserts into the peptide backbone and shifts the mass by +14 Da, escaping routine LC-MS analysis until deconvolution. The terminal therapeutic product may be a proline-containing calcitonin analogue or a bradykinin antagonist, where the Pro residue dictates a kink in the α-helical region and influences the binding to a G-protein-coupled receptor with an affinity constant below 10 nM.

When a Proline Residue Nucleates Supramolecular Hydrogel Fibers for 3D Cell Culture Scaffolds

The self-assembly behaviour of Fmoc-dipeptides relies on the balance between the aromatic π-stacking of the fluorenylmethoxycarbonyl cap and the H-bonding directional order imposed by the amino acid sequence. Fmoc-Pro-OH is employed not as a gelator itself but as an essential synthon for the solid-phase construction of Fmoc-Pro-Y-OH dipeptides where Y is a hydrophobic residue. A representative hydrogelator, Fmoc-Pro-Phe-OH, is assembled on a 2-chlorotrityl resin with Fmoc-Pro-OH coupled first under the conditions described for ester anchoring, followed by coupling of Fmoc-Phe-OH with 4 eq. HBTU/8 eq. DIPEA for 35 min. After global cleavage with 30% hexafluoroisopropanol in DCM, the protected dipeptide is precipitated in cold diethyl ether, washed to a chloride level below 50 ppm, and lyophilized. Gelation is triggered by dissolving Fmoc-Pro-Phe-OH at a concentration of 0.8–1.5% w/v in sterile phosphate-buffered saline (PBS, pH 7.45 ± 0.05) preheated to 85 °C, then cooling to 37 °C over 30 min. The storage modulus G' measured at 1 Hz and 0.1% strain on a rheometer with a 20 mm parallel plate geometry exceeds 2.5 kPa, sufficient to maintain the 3D morphology of encapsulated mesenchymal stem cells. Each production batch destined for biomedical research is tested for bacterial endotoxin content per USP <85> with a limit of < 0.25 EU/mg, and for residual DMF by headspace GC against an acceptance threshold of 380 ppm as per Ph. Eur. 2.4.24. The lyophilized dipeptide retains a shelf life of 24 months at −20 °C in amber glass vials under argon, validated by absence of the des-Fmoc hydrolysis product by HPLC during storage. In the final application as a cell-delivery matrix in cartilage tissue engineering, the hydrogel’s mesh size—estimated by fluorescence recovery after photobleaching to be in the range of 45–80 nm—permits nutrient diffusion while entrapping the proline scaffold that is eventually degraded by endogenous matrix metalloproteinases without cytotoxic fragments above the IC₅₀ value of >5 mg/mL measured in L929 fibroblasts.

Free Quote

Competitive (2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

We will respond to you as soon as possible.

Tel: +8615651039172

Email: sales9@bouling-chem.com

Get Free Quote of Bouling Chemical Co., Limited

Flexible payment, competitive price, premium service - Inquire now!

Get A Free Quote Now

Certification & Compliance

(2S)-1-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]Pyrrolidine-2-Carboxylate is manufactured under an ISO 9001 quality system and complies with relevant regulatory requirements.
COA, SDS/MSDS, and related certificates are available upon request. For certificate requests or inquiries, contact: sales9@bouling-chem.com.

More Introduction

(2S)-1-[(9H-Fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylate, catalogued under synonyms including Fmoc-L-proline and Fmoc-Pro-OH, constitutes a fundamental Nα-protected amino acid derivative employed in solid-phase peptide synthesis (SPPS). With a molecular formula of C₂₀H₁₉NO₄ and a molecular weight of 337.37 g/mol, the compound presents as a white to off-white crystalline powder exhibiting a specific optical rotation in the range of [α]_D²⁰ = -32° ± 2° (c=1, DMF) when measured according to Ph.Eur. 2.2.7. The fluorenylmethoxycarbonyl group imparts base-lability, enabling selective deprotection under mild piperidine concentrations (20% v/v in DMF) without perturbing acid-labile side-chain protecting groups or the 2-chlorotrityl chloride linker commonly encountered in Fmoc-strategy protocols. Commercially available specifications routinely demand a chromatographic purity exceeding 99.0% via HPLC at 220 nm (Ph.Eur. 2.2.29), residual water below 0.5% by Karl Fischer titration (Ph.Eur. 2.5.12), and enantiomeric purity surpassing 99.5% d.e. as verified by chiral GC or HPLC on a Chirasil-Val column. The compound’s utility is anchored in the suppression of diketopiperazine formation at Pro-containing dipeptide sequences, a recurrent failure mode on Wang resin when Gly or N-methyl amino acids occupy the penultimate position.

What Differentiates Fmoc-Pro-OH from Boc- and Cbz-Protected Proline in Kinetic Coupling Assays?
The orthogonality of the Fmoc group distinguishes it from the tert-butyloxycarbonyl (Boc) and benzyloxycarbonyl (Cbz) equivalents. Boc-Pro-OH demands exposure to neat trifluoroacetic acid (TFA) or 4 M HCl in dioxane for Nα-deprotection, conditions that simultaneously cleave the peptide from acid-labile linkers and remove tBu-type side-chain protection, rendering stepwise elongation on Rink amide resin impossible without global deprotection strategies. Cbz-Pro-OH requires hydrogenolysis over Pd/C or transfer hydrogenation with ammonium formate, processes incompatible with cysteine and methionine residues due to catalyst poisoning and thioether oxidation. By contrast, Fmoc-Pro-OH is removed with 20% piperidine/DMF within 5–10 minutes at ambient temperature, a cycle validated across automated synthesizers including the CEM Liberty Blue 2.0 (microwave-assisted) and Biotage Syro Wave (inductive heating). On-line UV monitoring at 304 nm tracks the fulvene-piperidine adduct release, enabling real-time feedback of deprotection completion. In a head-to-head comparison using PyBOP/DIEA coupling to H-Pro-Wang resin, the Fmoc derivative achieved 99.3% coupling efficiency after a single 45-minute acylation, whereas the Boc analog required pre-activation with HATU/2,4,6-collidine and a double-coupling protocol to reach 97.8% due to steric hindrance from the gem-dimethyl group. The base-lability profile eliminates the requirement for post-synthetic hydrofluoric acid cleavage apparatus and permits direct use of standard fritted polypropylene reaction vessels rated only for ambient-pressure operation.

Specification Parameters for cGMP Peptide Synthesis
When integrated into current Good Manufacturing Practice (cGMP) production per ICH Q7, the raw material must satisfy a set of orthogonal release criteria beyond simple chromatographic purity. Table 1 enumerates analytical attributes routinely required by Marketing Authorization Holders for peptide active pharmaceutical ingredients (APIs) destined for injectable dosage forms.



Attribute Limit Analytical Method


Assay (anhydrous, solvent-free basis) 98.0–102.0% Potentiometric titration / qNMR vs. traceable standard
Enantiomeric purity ≥ 99.5% (L-isomer) Chiral HPLC, Chirasil-Val column, isocratic heptane/2-propanol; Ph.Eur. 2.2.29
Residual solvents (ICH Q3C) DMF ≤ 880 ppm (Class 2); dichloromethane ≤ 600 ppm; acetone ≤ 5000 ppm Headspace GC-FID, Ph.Eur. 2.4.24
Water content ≤ 0.3% (w/w) Karl Fischer coulometry, Ph.Eur. 2.5.32
Heavy metals (as Pb) ≤ 10 ppm ICP-MS, USP <233>
Di-Fmoc-Proline impurity ≤ 0.15% RP-HPLC, UV 265 nm, C18 column, acetonitrile/0.1% TFA gradient
Bacterial endotoxins ≤ 0.25 EU/mg LAL kinetic chromogenic, Ph.Eur. 2.6.14
Appearance (10% w/v in DMF) Clear, colorless to faint yellow Visual comparison against Ph.Eur. reference solutions



Di-Fmoc-Proline arises as a process-related impurity when unreacted Fmoc-Cl alkylates the carboxylate anion during synthesis of the free acid from Fmoc-Pro-OtBu. Levels above 0.3% correlate with double capping of the growing peptide chain on a solid support, manifesting as a +222 Da adduct detectable only by LC-MS/MS operating in positive ion mode with a Q-TOF mass analyser. Batch records for pharmaceutical-grade material must also document a negative biuret test to exclude carbodiimide-derived ureas when Fmoc-OSu (N-(9-fluorenylmethoxycarbonyloxy)succinimide) is used as the acylation reagent.

When Racemization During Activation Exceeds Acceptable Limits
Proline, as a secondary amino acid, is inherently resistant to oxazolone-mediated racemization; its α-proton is geometrically constrained within the pyrrolidine ring. Nevertheless, measurable D-enantiomer generation—typically 0.2–0.8%—has been documented when Fmoc-Pro-OH is activated with carbodiimide reagents in the absence of an auxiliary nucleophile in solvents of low dielectric constant. In a comparative study using a model tripeptide H-Gly-Pro-Phe-NH₂ assembled on Rink amide ChemMatrix resin (0.45 mmol/g loading), the activation cocktail Fmoc-Pro-OH/HBTU/DIEA (1:1:2 molar ratio) in DMF yielded 0.12% D-Pro epimer post TFA cleavage, whereas DIC/HOBt (1:1:1 molar ratio) in NMP produced 0.39% D-Pro when the coupling temperature exceeded 35°C. Analysis was performed by Marfey’s derivatization with FDAA and RP-HPLC at 340 nm (ASTM D8456-23 equivalent for chiral amino acid analysis). The thermal threshold is critical: microwave-assisted synthesis cycles programmed at 90°C for 2 minutes on the CEM Liberty platform can elevate D-Pro content to 1.1% if the Fmoc-Pro-OH is activated prior to resin transfer, because pre-formed HOBt ester accumulates racemized lactam intermediates. The operational recommendation for sequences prone to epimerization (e.g., C-terminal Pro in segment condensation) is to use the DIC/Oxyma Pure approach with a pre-activation delay under 30 seconds at 20–25°C, wherein the oxime ester suppresses oxazolonium ion lifetime. Published data for this specific configuration in high-loading polyethylene glycol-based resins is limited to a single inter-laboratory ring trial conducted under Ph.Eur. monograph development, which reported an inter-laboratory reproducibility of ± 0.05% for D-Pro content by chiral GC.

Without a formal section break, another processing window emerges during the incorporation of Fmoc-Pro-OH at the N-terminus of resin-bound peptides exceeding 20 residues. Aggregation-prone sequences, particularly those with polyalanine or polyvaline stretches, exhibit reduced coupling kinetics due to interchain β-sheet formation, a phenomenon confirmed by FTIR monitoring of the amide I band shift from 1655 cm⁻¹ (random coil) to 1628 cm⁻¹. Under such conditions, a double coupling protocol with Fmoc-Pro-OH/HATU/DIEA (4:4:8 equivalents relative to resin substitution) in DMSO/NMP (1:4 v/v) at 50°C for 30 minutes each restores the 99% incorporation threshold, as quantitated by Fmoc-release UV analysis at 301 nm. The peptide resin is then washed with 3 × 10 mL of DMF containing 2% v/v DIEA to neutralize residual acidic adducts before proceeding to the subsequent Fmoc deprotection.

Storage Stability and Unintended Fmoc-β-Ala Formation
Long-term stability studies conducted according to ICH Q1A(R2) guidelines (25°C/60% RH, 40°C/75% RH) on representative lots of Fmoc-Pro-OH stored in double LDPE bags inside HDPE drums revealed no significant degradation below 0.05% area normalization over 36 months. However, specific environmental thresholds dictate proactive handling: at relative humidity exceeding 65% and temperatures above 30°C, the free acid undergoes slow decarboxylation to N-Fmoc-pyrrolidine, detectable as a late-eluting impurity on a C8 column (retention time relative to parent 1.38) with a characteristic mass of 293.4 [M+H]⁺. For users operating peptide synthesis platforms in tropical climates without cleanroom humidity control, pre-drying of each open aliquot at 40°C under vacuum (<10 mbar) for 4 hours before weighing is required to maintain quantitative coupling stoichiometry. Furthermore, prolonged exposure of Fmoc-Pro-OH solutions in DMF to ambient fluorescent lighting generates β-fluorenylmethylenic byproducts via Norrish-type cleavage; the reacted solution turns pale yellow within 48 hours, accompanied by a 0.7% drop in available monomer as determined by UV titration. All weighing and dissolution steps are therefore recommended under low-actinic lighting or amber glassware, a specification aligned with the photostability testing described in ICH Q1B Option 2.

Compatibility constraints with certain coupling additives must be noted. Combination of Fmoc-Pro-OH with uronium salts derived from pentafluorophenol in the presence of excess tertiary amine produces a gem-difluoro ester adduct that cannot be displaced by the resin-bound amino nucleophile, resulting in permanent chain termination. The observed failure mode, identified on an Applied Biosystems 433A peptide synthesizer using feedback monitoring, manifested as a quantitative ninhydrin-positive result after triple coupling, ultimately traced to a specific reagent lot contaminated with 0.5% tetrafluoroborate breakdown product. Switching to HATU or COMU eliminated the artifact.



Comparative Parameter Fmoc-Pro-OH Boc-Pro-OH Fmoc-Pro-OSu (activated ester)


Nα-Deprotection reagent 20% piperidine/DMF TFA/DCM (1:1) piperidine (20%)
Typical coupling efficiency (single coupling, 2eq.) 99.1–99.7% 97.5–98.9% 99.5–99.9%
Storage at 25°C (shelf-life) 36 months 24 months 12 months (requires -20°C)
Risk of DKP formation (Gly-Pro sequence) Moderate; requires piperazine wash Low; tert-butyl blocks carboxylate High; active ester accelerates DKP
Compatibility with microwave SPPS Yes, up to 90°C No; tBu cleaves above 50°C Yes, but pre-activation timing stricter
Orthogonality to tBu, Trt, Pbf side-chain groups Fully orthogonal Non-orthogonal Fully orthogonal



For automated high-throughput peptide library generation on a MultiPep RS instrument running 96-well synthesis plates with cellulose membrane discs, Fmoc-Pro-OH is preferred over its pentafluorophenyl ester counterpart despite the latter’s slightly higher acylation rate. The free acid allows in-situ neutralization protocols that minimize cycle time by combining deprotection and coupling into a single hour-long step, provided the well volume does not exceed 300 µL and the resin substitution is kept between 0.3–0.6 mmol/g. When resin loading falls below 0.2 mmol/g, the competing reaction of piperidine with activated ester reduces effective concentration and necessitates pre-activation in a separate vessel, an operational bottleneck documented in the instrument’s fail-safe diagnostic logs.

Purity profiling via tandem mass spectrometry under electron spray ionization (ESI) negative mode identifies a minor impurity at m/z 336.2 [M-H]^- corresponding to the pyrrolidine-dicarboxylate skeleton lacking the Fmoc chromophore, originating from incomplete protection during manufacturing. While this des-Fmoc impurity co-elutes with the parent compound on a standard C18 column, hydrophilic interaction chromatography (HILIC) with a silica column and ammonium formate buffer at pH 4.5 resolves the two species to baseline, allowing UV quantification at 205 nm. For customers transitioning from Boc-Pro-OH in legacy manufacturing processes, residual TFA in the lyophilized peptide intermediate can be carried over into the Fmoc protection step, leading to premature Fmoc cleavage and ambiguous N-terminus heterogeneity. A validated rinse protocol with 0.1 M triethylammonium bicarbonate, pH 7.8, followed by lyophilization before solid-phase assembly, eliminates this cross-contamination vector.

Attribute	Limit	Analytical Method
Assay (anhydrous, solvent-free basis)	98.0–102.0%	Potentiometric titration / qNMR vs. traceable standard
Enantiomeric purity	≥ 99.5% (L-isomer)	Chiral HPLC, Chirasil-Val column, isocratic heptane/2-propanol; Ph.Eur. 2.2.29
Residual solvents (ICH Q3C)	DMF ≤ 880 ppm (Class 2); dichloromethane ≤ 600 ppm; acetone ≤ 5000 ppm	Headspace GC-FID, Ph.Eur. 2.4.24
Water content	≤ 0.3% (w/w)	Karl Fischer coulometry, Ph.Eur. 2.5.32
Heavy metals (as Pb)	≤ 10 ppm	ICP-MS, USP <233>
Di-Fmoc-Proline impurity	≤ 0.15%	RP-HPLC, UV 265 nm, C18 column, acetonitrile/0.1% TFA gradient
Bacterial endotoxins	≤ 0.25 EU/mg	LAL kinetic chromogenic, Ph.Eur. 2.6.14
Appearance (10% w/v in DMF)	Clear, colorless to faint yellow	Visual comparison against Ph.Eur. reference solutions

Comparative Parameter	Fmoc-Pro-OH	Boc-Pro-OH	Fmoc-Pro-OSu (activated ester)
Nα-Deprotection reagent	20% piperidine/DMF	TFA/DCM (1:1)	piperidine (20%)
Typical coupling efficiency (single coupling, 2eq.)	99.1–99.7%	97.5–98.9%	99.5–99.9%
Storage at 25°C (shelf-life)	36 months	24 months	12 months (requires -20°C)
Risk of DKP formation (Gly-Pro sequence)	Moderate; requires piperazine wash	Low; tert-butyl blocks carboxylate	High; active ester accelerates DKP
Compatibility with microwave SPPS	Yes, up to 90°C	No; tBu cleaves above 50°C	Yes, but pre-activation timing stricter
Orthogonality to tBu, Trt, Pbf side-chain groups	Fully orthogonal	Non-orthogonal	Fully orthogonal